New and Generic Drug Approvals from FDA

NewsGuard 100/100 Score
Apr 14 2004

Inactive Ingredient Database (updated)

Related Stories

  • New and Generic Drug Approvals
    • Colgate Total Toothpaste, Colgate-Palmolive Company
    • Heparin Sodium in 5% Dextrose Injection, B. Braun Medical Inc.
    • Heparin Sodium in 0.9% Sodium Chloride Injection, B. Braun Medical Inc.
    • Lovenox (enoxaparin sodium) Injection, Aventis Pharmaceuticals
    • Terconazole Vaginal Cream, Taro Pharmaceuticals
    • Tylenol Arthritis Pain (650 mg acetaminophen) extended release tablets, McNeil Consumer

Posted in: Pharmaceutical News

Tags: , , , , , ,

Comments (0)

Suggested Reading

The Lancet Breast Cancer Commission: Tackling inequalities, hidden costs, and empowering patients
Croatian sea fennel may contain a treasure trove of preservative and anti-aging metabolites
Natural obesity fighters: How coffee, tea, and cocoa combat weight gain
Lancet Commission predicts sharp increase in global prostate cancer cases
New urine-based test improves identification of high-grade prostate cancer
Common HIV drugs linked to reduced Alzheimer's disease risk
Pembrolizumab enhances breast cancer treatment regardless of age or menopausal status
MD Anderson acquires cell therapy safety technology from Bellicum Pharmaceuticals

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
LabVantage celebrates customer success with record number of software deployments in FY 2024